|
 |
|
This 7th annual multi-disciplinary CME conference is dedicated to further advancing knowledge and expertise in the complex field of Cardiovascular-Thoracic (CVT) Critical Care. It is designed to bring together the entire team of health care professionals that provide care for patients undergoing CVT operations and procedures, including now endovascular procedures.
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Association for Thoracic Surgery (AATS) and the Foundation for the Advancement of CardioThoracic Surgical Care. The AATS is accredited by the ACCME to provide continuing medical education for physicians.
| |
Omni Shoreham Hotel |
|
2500 Calvert St NW, Washington, DC 20008 |
|
|
|
|
|
|
|
 Description »
|
|
 |
|
|
|
|
This 7th annual multi-disciplinary CME conference is dedicated to further advancing knowledge and expertise in the complex field of Cardiovascular-Thoracic (CVT) Critical Care. It is designed to bring together the entire team of health care professionals that provide care for patients undergoing CVT operations and interventional procedures.
The conference is directed to:
|
|
Surgeons, Cardiologists, Interventionalists
|
|
|
Intensivists & Anesthesiologists
|
|
|
|
|
|
Critical Care Nurses / Nurse Practitioners
|
|
|
|
|
|
|
|
|
Cath Lab Technicians |
|
|
|
|
|
Respiratory Therapists |
|
|
|
The conference addresses the unique physiology, operations, procedures, and potential complications of CVT patients. Latest management strategies for challenging clinical problems will be presented and current controversies discussed. Experts and world authorities will focus on the latest concepts, technology, management protocols, and clinical experience in their specialties.
The program includes faculty presentations, symposia regarding major issues, audience-panel discussions and workshops. Approaches and specific protocols will be related to clinical data, so that participants can structure their clinical practice on evidence-based medicine.
With the field of CVT critical care continuing to change rapidly, it is anticipated that participation in the conference will lead to implementation of new concepts, protocols, and technology. The overall goal is to make the recovery of patients from CVT surgery and interventional procedures faster, safer, and more comfortable.
|
|
|
|
|
|
|
|
|
Fee Structure »
|
|
|
|
|
|
|
Take advantage of Early Bird pricing and register by August 31, 2010. Members receive a 15% discount of all prices below. Become a Member today!
|
|
|
Allied Health Professionals
|
|
Full Conference (Early Bird - before 8/31)
|
|
|
|
Full Conference (After 8/31)
|
|
|
|
|
|
|
|
|
Thursday and Saturday only
|
|
|
|
|
Friday and Saturday only |
|
|
|
|
Thursday only |
|
|
|
|
Friday only |
|
|
|
|
Saturday only |
|
|
|
|
|
|
|
|
|
Members of the following organizations receive a 15% discount on both the early and full conference registration fees: AATS, STS, SCA (Soc of CV Anes). |
|
|
|
|
|
Contact Us »
Needs Assessment »
|
|
|
|
|
|
|
Cardiovascular-thoracic (CVT) critical care is being recognized as an emerging specialty within the frameworks of CVT surgery, interventional cardiology, interventional radiology and general critical care. The overall field of cardiovascular-thoracic care is broadening to include care of patients undergoing not only classical cardiac surgical operations but also endovascular and minimally invasive surgery, interventional cardiology procedures, and interventional radiological procedures.
Although the cardiovascular-thoracic surgeon has traditionally provided perioperative care with the assistance of residents and fellows, the organization of the CVT critical care team is changing. CVT critical care is increasingly being provided by a multi-disciplinary team. The team includes: CVT surgeons, intensivists and anesthesiologists, hospitalists, critical care nurses and nurse practitioners, physician assistants, perfusionists, cath lab technicians, respiratory therapists, pharmacists, and nutritionists. It is essential that these multi-disciplinary professionals share a broad understanding of the care, so that they can function well as a team to enhance speed of recovery, quality, safety, and patient comfort.
The increasing complexity of CVT critical care requires a new level of critical care performance. This new critical care specialty is faced with major challenges:
|
|
A rapid evolution in critical care concepts, pharmacology and technology.
|
|
|
The unique physiologic states and complications experienced by CVT patients.
|
|
|
The aging CVT patient population with more advanced primary disease and associated conditions.
|
|
|
Major advances in surgical techniques, interventional procedures and the accompanying technology.
|
|
|
Newly-adopted national regulations limiting house staff work hours that accentuate the shortage of critical care staff.
|
|
|
The difficulty in providing comfortable care with patients subjected to multiple negative sensory inputs including monitoring sounds, alarms, technical language, and procedures.
|
|
|
The increasing number of disciplines included on the CVT critical care team. |
|
|
The well-documented compromises in medical practice safety. |
This 7th annual multi-disciplinary course, “Cardiovascular-Thoracic (CVT) Critical Care 2010,” addresses these challenges as follows:
|
|
The conference is dedicated to presenting the latest information and innovative concepts and technology in CVT Critical Care.
|
|
|
Basic approaches and specific protocols will be related to clinical data so that participants can structure their clinical practice on “evidence based medicine.”
|
|
|
The program agenda has been designed with the assistance of multi-disciplinary specialists.
|
|
|
Experts and world authorities will present the latest concepts, protocols and clinical experience in their specialties
|
|
|
Participants will be encouraged to add their perspectives to the dialogue via a Luncheon Symposia on “Communications in the CVT ICU” and “Maintaining and Building the CVT ICU Staff” and through audience-panel discussions throughout the program.
|
|
|
The Keynote Address will focus the future of Cardiovascular Health Care
|
In the last few years, there have been important new developments in the specialty which have the potential to enhance the quality and safety of CVT critical care. This conference addresses the major need to highlight this new knowledge so that these developments can be widely known and integrated into the practices of the specialty. Examples of such developments include:
|
|
New methods of hemodynamic monitoring which are less invasive. An important consideration to be addressed is how well the new methods guide hemodynamic management. This topic will be explored through presentations, panel discussions, and hemodynamic simulation workshops.
|
|
|
There is an evolution in cardiovascular therapeutic agents to address the challenges of low cardiac output, right heart failure, and pulmonary hypertension. New pharmacologic approaches will be presented and discussed in the audience panel discussions
|
|
|
New approaches to resuscitation after cardiac arrest are being developed and will be the subject of a major presentation and be discussed in an audience –panel discussion
|
|
|
Protocols for blood pressure management and drainage of cerebrospinal fluid are evolving to increase the safety of aortic surgical and interventional procedures
|
|
|
Safety management principles learned from the aviation industry are being applied to medical practice. Implications for CVT critical care will be discussed.
|
|
|
Difficult problems weaning patients from ventilators continue to challenge critical care teams. The use of the latest modes of mechanical ventilation for difficult weaning problems will be presented in the main conference session as well as illustrated in a workshop
|
|
|
The technology to provide circulatory support continues to evolve rapidly and now includes a variety of percutaneous devices. The postoperative management of patients on such devices is complex and will be addressed through presentations and workshops
|
|
|
Extra-corporeal membrane oxygenation (ECMO) has been employed for the treatment of acute respiratory failure caused by H1N1 and other viral pneumonias. New information regarding the application of ECMO to this challenging area will be the subject of a presentation and will be addressed in a workshop.
|
|
|
The development of bedside ultrasound technology now makes possible early bedside diagnosis of mechanical hemodynamic problems and can be used to safely guide placement of deep catheters. The workshop dedicated to this area will facilitate integration of these techniques into clinical practice
|
|
|
New technology is becoming available to monitor coagulation and platelet function abnormalities. This topic will be addressed in a presentation and in an audience panel discussion
|
|
|
New pharmacologic agents are being used to anticoagulate CVT patients. This area will be discussed
|
|
|
The important concept of “Goal Directed Therapy” has continued to evolve and its application to CVT critical care will be presented
|
|
|
It is well-recognized that there are important risks of blood product transfusions. Latest protocols to reduce blood product utilization will be presented
|
|
|
Achieving adequate and safe sedation in CVT patients and treating delirium are continuing challenges in the CVT ICU. Latest data and management protocols will be presented
|
|
|
It is well recognized that optimal communications in the CVTICU are a challenge. Issues related to information transfer and handoff from the OR or cath lab to the CV ICU will be discussed. A second important area of communications to be discussed will be coordination of plans among the multi-disciplinary team members
|
|
|
Management of pulmonary and esophageal complications after thoracic surgery continue to challenge the CVT ICU team and will be discussed.
|
|
|
Nutritional support for patients in respiratory, renal, or hepatic failure are particularly challenging and will be addressed.
|
|
|
Good communications between health care personnel and their patients are challenging especially in sedated and ventilated patients. To help critical care personnel understand the patient’s perspective, a discussion led by the patient organization Mended Hearts will be presented.
|
|
|
A continuing challenge in CVT critical care patients is the management of the “difficult airway” with the risk of severe complications if management is not properly carried out. This important area will be the subject of a workshop
|
|
|
Acute renal failure associated with cardiac surgery continues to be a major challenge and is associated with an important increase risk of mortality and prolonged hospitalization. A presentation and workshop will focus on the early use of renal replacement therapy
|
|
|
It is well recognized that antibiotic resistant organisms require special considerations related to prevention and treatment. This area will be discussed. |
|
|
Multiple-organ system failure continues to an extremely challenging clinical situation. Latest concepts and therapeutic approaches will be presented. |
|
|
|
|
|
|
|
|
|
Educational Objectives »
|
|
|
|
|
|
|
The overall educational objectives of Cardiovascular-Thoracic (CVT) Critical Care 2010 are:
|
|
|
|
Understand the latest developments and challenges in the specialty of CVT critical care.
|
|
|
|
Understand the use of protocols and new technology to increase speed of recovery, safety and patient comfort.
|
|
|
Recognize the importance of the multi-disciplinary team approach in CVT critical care and how the team works together.
|
| The specific educational objectives of Cardiovascular-Thoracic (CVT) Critical Care 2010 are: |
|
|
|
Understand the pharmacologic approach to right heart failure and pulmonary hypertension in the CVT critical care patient. |
| |
|
Understand and integrate into practice the latest approaches to resuscitation after cardiac arrest. |
| |
|
Understand procedures related to aortic surgery and aortic interventional procedures for management of systemic blood pressure and cerebrospinal fluid drainage. |
|
|
Obtain a perspective of how safety management protocols in the aviation industry relate to increasing safety in the CVT intensive care unit. |
|
|
Gain an understanding of the future of cardiovascular health care. |
|
|
Understand how the latest modes of mechanical ventilation are used for difficult weaning situations. |
|
|
Understand how ECMO technology is used for patients with acute respiratory failure related to H1N1 and other viral pneumonias. |
|
|
Understand how current ventricular assist devices are employed in CVT critical care. |
|
|
Understand how the latest bedside echocardiography- ultrasound technology is used to diagnosis hemodynamic mechanical problems and to guide placement of deep catheters. |
|
|
Understand how coagulation and platelet function abnormalities are monitored and managed in CVT patients. |
|
|
Assess the latest advances in anticoagulation for interventional procedures. |
|
|
Understand how the principles of “goal directed therapy” apply to the CVT critical care patient. |
|
|
Understand how to integrate into practice the latest protocols to reduce blood product utilization. |
|
|
Integrate into practice the latest protocols for management of sedation and the treatment of delirium. |
|
|
Understand the patient’s perspective in regard to receiving critical care in the ICU. |
|
|
Understand issues related to communications in the CVT ICU regarding information transfer and coordination of plans among members of the multi-disciplinary team. |
|
|
Integrate into practice principles of managing pulmonary and esophageal complications after thoracic surgery. |
|
|
Gain an understanding of the latest methods of nutritional support for patients with respiratory, hepatic, or renal failure. |
|
|
Understand the potential complications of managing patients with “difficult airways” and how to overcome the complexities involved. |
|
|
Understand issues and solutions for maintaining and building the CVT ICU Staff. |
|
|
Integrate into practice management protocols to prevent and treat infections caused by antibiotic resistant organisms. |
|
|
Understand how renal replacement therapy is employed for acute renal failure after cardiac surgery. |
|
|
Understand the latest concepts and management strategies in multi-organ system failure. |
| |
|
|
|
|
|
|
|
|
|
|
|
CE Accreditation »
|
|
|
|
|
|
|
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the American Association for Thoracic Surgery (AATS) and the Foundation for the Advancement of CardioThoracic Surgical Care. The AATS is accredited by the ACCME to provide continuing medical education for physicians.
This activity has been approved or 19.75 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Nurse Accreditation:
Continuing education for nurses will be provided by Educational Review Systems (ERS). ERS is an approved provider of continuing education in nursing by ASNA, an accredited provider by the ANCC/ Commission on Accreditation. Provider # 5-115. ERS is also approved for nursing continuing education by the state of Cali¬fornia, the state of Florida, and the District of Columbia.
Perfusionist Accreditation: The American Board of Cardiovascular Perfusion (ABCP) designates this educational activity for a maximum of 23.80 Category 1 CEUs. Perfusionists should only claim credits commensurate with the extent of their participation in the activity.
Faculty Disclosureand Resolution of COI
As an accredited provider of continuing medical education, it is our policy to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. Additionally, in the event a conflict of interest (COI) does exist, it is our policy to ensure that the COI is resolved in order to ensure the integrity of the CME activity. Disclosures and resolution will be included in the on-site program materials.
|
|
|
|
|
|
|
|
|
Group Rate Hotel Information »
|
|
|
|
|
|
|
Omni Shoreham Hotel Washington, DC
The Omni Shoreham Hotel welcomes attendees of Cardiovascular-Thoracic Critical Care 2010. To reserve your room now and receive the special conference rate simply click on the "book now" button below.
Conference Dates: September 30, 2010 - October 2, 2010
Additional Dates: September 24 - October 5
Special Rate: $242 per night Book Now »
Book By: September 8, 2010
|
|
|
|
|
|
|
|
|
Agenda »
|
|
|
|
|
|
|
Preliminary Agenda for Thursday, Friday, and Saturday. Please note: Agenda and Faculty subject to change.
Thursday -September 30, 2010
|
|
|
|
7:00 am - 8:00 am |
Light Breakfast & Registration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 am - 8:10 am |
Welcome and Introduction to the Program |
|
Nevin M. Katz, MD |
|
8:10 am – 8:30 am |
CVT Critical Care: Where are We? – Issues & Challenges Ahead |
|
Nevin M. Katz, MD |
|
8:30 am – 9:00 am |
Right Heart Failure & Pulmonary Hypertension: The Pharmacologic Approach |
|
Erik E. Abel, PharmD |
|
9:00 am – 9:45 am |
Latest Approaches to Resuscitation after Cardiac Arrest |
|
Keith Lurie, MD |
|
9:45 am – 10:15 am |
CSF Drainage & Blood Pressure Management for Aortic Surgery |
|
Edward P. Chen, MD |
|
10:15 am - 10:45 am |
Refreshment Break - Exhibit Hall |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |
10:45 am – 11:15 am |
Audience Panel Discussion |
|
Moderator: John V. Conte, MD |
|
|
|
|
Panelists: Erik E. Abel, PharmD, Edward P. Chen, MD, Regina Deible, RN, Keith Lurie, MD, Robert Molyneaux, PA-C, Denese Sabatino, CCRN |
|
11:15 am – 11:45 am |
Safety Management in the Air and Implications for Hospital Practice |
|
Steven B. Wallace, Former Director, Office of Accident Investigation, Federal Aviation Administration |
|
11:45 am – 12:00 pm |
Refreshment Break - Exhibit Hall |
|
|
|
Luncheon Symposium |
|
|
|
|
12:00 pm – 1:15 pm |
KEYNOTE ADDRESS: The Future of Health Care in the United States |
|
TBA |
|
|
Audience Panel Discussion |
|
Moderator: Nevin Katz, M.D., Panel: John V. Conte, MD, & Steven B. Wallace |
|
1:15 pm – 1:30 pm |
Exhibit Hall and Networking |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
1:30 pm - 2:00 pm |
Latest Modes of Mechanical Ventilation |
|
Dean R. Hess, PhD, RRT |
|
2:00 pm – 2:30 pm |
ECMO for H1N1 and other Viral Pneumonias |
|
William R. Lynch, MD |
|
2:30 pm – 3:00 pm |
Postoperative Management of Patients with Ventricular Assist Devices |
|
Jonathan W. Haft, MD & Mary J. Zellinger, CCRN |
|
3:00 pm – 3:30 pm |
Audience Panel Discussion |
|
Moderator: John V. Conte, MD |
|
|
|
|
Panelists: David C. Fitzgerald, CCP, Jonathan W. Haft, MD, Dean R. Hess, PhD, RRT, William R. Lynch, MD, Mary J. Zellinger, CCRN |
|
3:30 pm – 4:00 pm |
Refreshment Break - Exhibit Hall |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
4:00 pm – 6:00 pm |
Multi-Disciplinary Break Out Workshops |
|
|
|
|
Ventilator Technology to Address Difficult Weaning: 3-4 Stations |
|
Dean R. Hess,PhD, RRT, Respiratory Therapists TBA |
|
|
Temporary Circulatory Support / ECMO |
|
Jonathan W. Haft, MD, William R. Lynch, MD, David C. Fitzgerald, CCP, Mary J. Zellinger, CCRN |
|
|
Bedside Echocardiography & Ultrasound Guided Procedures |
|
Yanick Beaulieu, MD |
|
|
|
|
|
|
|
|
|
|
|
Light Breakfast & Registration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 am – 8:20 am |
Monitoring & Management of Platelet Function Abnormalities |
|
Harold L. Dauerman, MD |
|
8:20 am- 8:50 am |
Latest Advances in Anticoagulation for Interventional Procedures |
|
Harold L. Dauerman, MD |
|
8:50 am – 9:20 am |
Goal Directed Therapy in the CVT ICU |
|
Emanuel P. Rivers, MD,MPH |
|
9:20 am – 9:50 am |
Latest Protocols to Reduce Blood Product Utilization |
|
Bruce D. Spiess, MD |
|
9:50 am – 10:15 am |
Audience Panel Discussion |
|
Moderator: Bruce D. Spiess, MD |
|
|
|
|
Panelists: Harold L. Dauerman, MD, Emanual P. Rivers,MD, MPH, Tammy Slater, CRNP, Robert Warhurst, Pharm D |
|
10:15 am - 10:45 am |
Refreshment Break - Exhibit Hall |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
10:45 am – 11:15 am |
An Update on Sedation, Delirium, and Cerebral Monitoring |
|
Namrata Patil, MD, MPH |
|
11:15 am – 11:30 am |
Audience Panel Discussion |
|
Moderator: Fred Mollenkoft, PA-C |
|
|
|
|
Panelists: Namrata Patil, MD, Tammy Slater, CRNP, Robert Warhurst, Pharm D |
|
11:30 am – 12:00 pm |
The Patient’s Perspective Panel: TBA |
|
Mended Hearts Moderator & Representatives |
|
Luncheon Symposium |
|
|
|
|
12:00 pm – 1:15 pm |
Communications in the CVT ICU |
|
Moderator: Glenn Whitman, MD |
|
|
-Information Transfer & Handoff from the OR & Cath Lab to the CVT ICU |
|
Panelists: Danielle Blais,Pharm D, David Fitzgerald, CCP, Marsha Holton, CCRN, RCIS, |
|
|
-Coordination of Plans among CT Surgeons, Intensivists, and Advanced Practice Providers |
|
Robert Molyneaux, PA-C, Natalie Napolitano, RRT, Geoffrey R. Sheinfeld, MD, & Tammy Slater, CRNP |
|
1:15 pm – 2:00 pm |
Exhibit Hall with Demonstrations |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
2:00 pm – 2:30 pm |
Management of Pulmonary and Esophageal Complications |
|
Daniel L. Miller, MD |
|
2:30 pm – 2:50 pm |
Management of Chest Wall Instability |
|
Daniel L. Miller, MD |
|
2:50 pm – 3:00 pm |
Audience-Panel Discussion |
|
Moderator: Geoffrey R. Sheinfeld, MD |
|
|
|
|
Panelists: Daniel L. Miller, MD, Mary J. Zellinger, CCRN |
|
3:00 pm – 3:20 pm |
Andrew Foster “Young Investigator” Presentation |
|
Award Recipient and Joseph M. Giordano, MD |
|
3:20 pm – 4:00 pm |
Poster Session - Refreshment Break - Exhibit Hall |
|
|
|
|
|
|
|
|
Session VIII |
|
|
|
|
|
|
|
|
| |
4:00 pm - 6:00 pm |
Multi-Disciplinary Break Out Workshop |
|
|
| |
|
Hemodynamic Simulation – Case Scenarios |
|
Nevin Katz, MD |
|
|
Difficult Airway Management |
|
Thomas C. Mort, MD |
|
|
Renal Replacement Technology |
|
Geoffrey R. Sheinfeld, MD |
|
|
|
Saturday - October 2, 2010
|
|
|
|
|
Light Breakfast & Registration |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
8:00 am – 9:00 am |
Maintaining and Building the CVT ICU Staff - |
|
Connie Barden, CCRN & Mary J. Zellinger, CRNP |
|
|
Solutions for Critical Care Nurses Leaving the Bedside for Advanced Practice |
|
|
|
|
|
|
|
Audience-Panel Discussion |
|
Moderator: Mary J. Zellinger, CRNP |
|
|
|
|
Panelists: Connie Barden, CCRN, Barbara Jacobs, CCRN, Denese Sabatino, CCRN, Geoffrey Sheinfeld, MD |
|
9:00am - 9:30 am |
Update on Antibiotic Resistant Organisms |
|
Philip S. Barie, MD |
|
9:30 am - 9:45 am |
Audience-Panel Discussion / Brief Refreshment Break |
|
Moderator: Michael G. Seneff, MD |
|
|
|
|
Panelists: Philip S. Barie, MD, Barbara Jacobs, CCRN, & Geoffrey R. Sheinfeld, MD |
|
9:45 am - 10:15 am |
Nutritional Support for Respiratory, Hepatic, and Renal Failure |
|
TBA |
|
10:15 am – 10:45 am |
Renal Replacement Therapy: Early vs. Late, Intermittent vs. Continuous |
|
Geoffrey R. Sheinfeld, MD |
|
10:45 am – 11:15 am |
Multi-Organ System Failure |
|
Philip S. Barie, MD |
|
11:15 am |
Closing Comments |
|
Nevin M. Katz, MD |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Faculty »
|
|
|
|
|
|
|
Preliminary Faculty - Agenda and Faculty subject to change.
|
|
Nevin M. Katz, MD
President, FACTS-Care
Clinical Professor of Surgery
The George Washington University
Washington, DC
|
|
Conference Co-Directors |
Daniel L. Miller, MD
Chief, General Thoracic Surgery
Professor of Thoracic Surgery
Emory University
Atlanta, GA
Michael G. Seneff, MD
Director, Intensive Care Unit
Professor of Anesthesiology
The George Washington University
Washington, DC
|
|
|
Erik Abel, PharmD
Cardiothoracic Surgery Specialty Pharmacist
Clinical Assistant Professor
The Ohio State University Medical Center
Columbus, OH
Connie Barden, MSN, CCRN, CCNS
Clinical Nurse Specialist-eICU
Baptist Health South Florida
Miami, FL
Philip S. Barie, MD
Chief of Critical Care and Trauma
Professor of Surgery
Weill Cornell Medical Center
New York, NY
Yanick Beaulieu, MD
Director, Bedside Ultrasound Curriculum
Hopital Sacre-Coeur de Montreal
Montreal, Quebec, Canada
Danielle Blais, PharmD
Cardiothoracic Surgery Specialty Pharmacist
Clinical Assistant Professor
The Ohio State University Medical Center
Columbus, OH
Edward P. Chen, MD
Assistant Professor
Division of Cardiothoracic Surgery
Emory University
Atlanta, GA
John V. Conte, MD
Surgical Director, Heart Transplantation
Johns Hopkins Hospital
Professor of Surgery
Johns Hopkins University
Baltimore, MD
Harold L. Dauerman, MD
Director, Cardiovascular Catherization Laboratories
Professor of Medicine
University of Vermont
Burlington, VT
Regina Deible, BSN, RN
NIH Heart Center at Suburban Hospital
Bethesda, MD
David C. Fitzgerald, CCP
Chief of Cardiovascular Perfusion
ECMO Coordinator
INOVA Fairfax Hospital
Falls Church, VA
Joseph M. Giordano, MD
Professor & Chairman
Department of Surgery
The George Washington University
Washington, DC
Jonathan W. Haft, MD
Director, Extra-Corporeal Life Support
Assistant Professor of Surgery
University of Michigan
Ann Arbor, MI
Dean R. Hess, PhD, RRT
Respiratory Care, Massachusetts General Hospital
Associate Professor of Anesthesia
Harvard Medical School
Boston, MA
Marsha Holton, CCRN, RCIS
Interim Program Director
School of Cardiovascular Technology
Howard Community College
Columbia, MD
Barbara Jacobs, RN, CCRN
Director, Critical Care
The George Washington University Hospital
Washington, DC
Keith Lurie, MD
Professor of Medicine & Emergency Medicine
University of Minnesota
Minneapolis, MN
William R. Lynch, MD
Assistant Professor
Department of Cardiothoracic Surgery
University of Iowa
Iowa City, Iowa
Daniel L. Miller, MD
Chief, General Thoracic Surgery
Professor of Thoracic Surgery
Emory University
Atlanta, GA
Fred Mollenkopf, PA-C
Thoracic & Cardiovascular Surgery & Critical Care
Thoracic & Cardiovascular Institute
Lansing, MI
Robert E. Molyneaux, PA-C
Chief Physician Assistant
Surgical Critical Care Services
Washington Hospital Center
Washington, DC
Thomas C. Mort, MD
Associate Director, Surgical ICU
Medical Director, Simulation Center
Associate Professor of Anesthesiology & Surgery University of Connecticut Hartford Hospital
Hartford, CT
Natalie Napolitano, MPH, RRT-NPS, RCP IV
Respiratory Care Services
Inova Fairfax Hospital
Falls Church, VA
Namrata Patil, MD, MPH
Director, Thoracic Intermediate Care Unit
Associate Surgeon
Brigham & Womens’s Hospital
Instructor in Surgery
Harvard Medical School
Boston, MA
Emanuel P. Rivers, MD, MPH
Vice Chairman & Research Director
Department of Emergency Medicine
Henry Ford Hospital
Clinical Professor
Wayne State University
Detroit, MI
Denese Sabatino, ARNP, NP-C, CCRN
Critical Care Services
Baptist Hospital
Miami, FL
Michael G. Seneff, MD
Director, Intensive Care Unit
Professor of Anesthesiology
The George Washington University
Washington, DC
Geoffrey R. Sheinfeld, MD
Medical Director, Extracorporeal Therapies
Assistant Professor of Medicine & Surgery
R Adams Crowley Shock Trauma Center
University of Maryland
Baltimore, MD
Tammy M. Slater, CRNP
Acute Care Nurse Practitioner
Johns Hopkins Hospital
Emory University
Baltimore, MD
Bruce D. Spiess, MD
Professor of Anesthesiology
Virginia commonwealth University
Richmond, VA
Steven B. Wallace
Former Director, Office of Accident Investigation
Federal Aviation Administration
Washington, DC
Robert Warhurst, PharmD
CV Critical Care Pharmacist
Clarian Health – Methodist Hospital
Indianapolis, IN
Glenn Whitman, MD
Director, Cardiac SICU
Johns Hopkins Hospital
Associate Professor of Surgery
Johns Hopkins University
Baltimore, MD
Mary J. Zellinger, RN, MN, ANP-BC, CCRN-CSC
Clinical Nurse Specialist
Cardiovascular and Critical Care Services
Emory University Hospital
Atlanta, GA
|
|
|
|
|
|
|
|
|
|
Abstract Submission for Posters and Awards »
|
|
|
|
|
|
|
Abstract Submissions for the General Poster Session are encouraged from all disciplines and age groups! Abstracts should be emailed to info@facts-care.org and adhere to the following guidelines.
All abstracts must include the following information:
|
|
Name and degree(s) of all authors, with presenting author's name listed in upper case
|
|
|
Brief title of the abstract, including the nature of the study only
|
|
|
Do not underline the title |
In the abstract text, include the following information:
|
|
A concise statement of the investigation's purpose
|
|
|
A brief explanation of the study's materials and methods
|
|
|
A summary of the study's results
|
|
|
Conclusions supported by the investigation's results
|
Do not include references or graphics. Your abstract should not exceed 500 words. Deadline for the abstract is August 15, 2010.
|
|
This award honors the memory of Andrew H. Foster, MD, former chief of the Division of Cardiothoracic Surgery and Associate Professor of Surgery at The George Washington University Medical Center. Dr. Foster lost his battle with lymphoma in July, 1999.
The Andrew H. Foster, MD Young Investigator Award will be given to a young investigator (aged less than 35 years) whose abstract describing research related to Cardiovascular-Thoracic Critical Care is selected best by the Research Conference Committee. Abstracts will be judged using a blinded format.
|
|
|
|
|
|
Include the following contact information and if you would like to be considered for the Andrew Foster Award (you must meet the criteria as indicated below on this page) for the presenting author on a cover page.
The Program Committee members will review your abstract, and you will be notified of their decision by Sept 1, 2010.
If your abstract is selected, you will be asked to present it as either (a) a poster only or (b) a 10 minute conference presentation on October 1, 2010, as the winner of the Andrew Foster Award . You will receive complete information (including poster dimensions, set-up times, etc.) after notification of the Program Committee's decision.
If accepted for presentation or display, your abstract will be printed in the course syllabus as submitted, so please edit and proofread carefully.
If you have any questions about the above guidelines, please contact:
Nevin Katz, MD
President & Executive Director, FACTS-Care
Email: info@facts-care.org
or
Mowahib Vermillion
Administrative Assistant, FACTS-Care
Email: info@facts-care.org
|
|
|
|
|
|
|
|
|
Advisory Board »
|
|
|
|
|
|
|
|
Connie Barden, RN, MSN,CCRN,CCNS
Mercy Hospital
Robert H. Bartlett, MD
University of Michigan
Danielle Blais, Pharm D
Ohio State University Medical Center
John V. Conte, MD
Johns Hopkins University
Philip C. Corcoran, MD
NIH Heart Center at Suburban Hospital
Priscilla Daetwyler
Mended Hearts
Joseph A. Dearani, MD
Mayo Clinic
David C. Fitzgerald, CCP
INOVA Fairfax Hospital
Michael A. DeGeorgia, MD
Cleveland Clinic
Farid Gharagozloo MD
Wash Institute Thoracic & CV Surgery
Guillermo Gutierrez, MD, PhD
George Washington University Medical Center
Jonathan W. Haft, MD
University of Michigan
William E. Harris, BS CCP
Ochsner Clinic
Dean R. Hess, PhD, RRT
Massachusetts General Hospital
Barbara Jacobs, RN, CCRN
George Washington University Hospital
Eric Jacobsohn, MBChB, MHPE, FRCP
University of Manitoba
C. David Joffe MD
Dayton Heart & Vascular Hospital
Jerrold H. Levy, MD
Emory University
|
Fred Lough, MD
George Washington University Hospital
William R. Lynch, MD, MS
University of Iowa
Elizabeth A. Martinez, MD
JohnsHopkins University
Frederick P. Mollenkopf, PA-C
Thoracic Cardiovascular Institute
Claudio Pensa, MD
FLENI - Buenos Aires, Argentina
Peter J. Pronovost, MD, PhD
Johns Hopkins University
James D. Rawn, MD
Harvard University
Charles A. Read, MD
Georgetown University
Dennis Rivard, CCP
Johns Hopkins Hospital
Claudio Ronco, MD
San Bortolo Hospital - Vicenza Italy
Gary Roth, DO
Thoracic Cardiovascular Institute
Michael G. Seneff, MD
George Washington University Medical Center
Tammy Slater, CRNP
Johns HopkinsUniversity
Manak Sood MD
Michigan Heart & Vascular Institute
Anthony C. Venbrux, MD
George Washington University Medical Center
Robert D. Warhurst, PharmD
Clarian Health
Mary J. Zellinger, CRNP
Emory University |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Council for Excellence
We wish to thank our supporters who have made the society and this conference possible:
|
|
|
|
|
|
|
|
|
2010 Exhibitors »
|
|
|
|
|
|
|
We would like to thank the following companies for their exhibit support:
Gold Exhibitors:
Silver Exhibitors:
Bronze Exhibitors:
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
